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Abstract
Aim: N-acyl dopamines (NADD) are gaining attention in the field of inflammatory and neurological disorders. Due to their
hydrophobicity, NADD may have access to the endoplasmic reticulum (ER). We therefore investigated if NADD induce the
unfolded protein response (UPR) and if this in turn influences cell behaviour.
Methods: Genome wide gene expression profiling, confirmatory qPCR and reporter assays were employed on human
umbilical vein endothelial cells (HUVEC) to validate induction of UPR target genes and UPR sensor activation by N-octanoyl
dopamine (NOD). Intracellular ATP, apoptosis and induction of thermotolerance were used as functional parameters to
assess adaptation of HUVEC.
Results: NOD, but not dopamine dose dependently induces the UPR. This was also found for other synthetic NADD.
Induction of the UPR was dependent on the redox activity of NADD and was not caused by selective activation of a
particular UPR sensor. UPR induction did not result in cell apoptosis, yet NOD strongly impaired cell proliferation by
attenuation of cells in the S-G2/M phase. Long-term treatment of HUVEC with low NOD concentration showed decreased
intracellular ATP concentration paralleled with activation of AMPK. These cells were significantly more resistant to cold
inflicted injury.
Conclusions: We provide for the first time evidence that NADD induce the UPR in vitro. It remains to be assessed if UPR
induction is causally associated with hypometabolism and thermotolerance. Further pharmacokinetic studies are warranted
to address if the NADD concentrations used in vitro can be obtained in vivo and if this in turn shows therapeutic efficacy.
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Introduction
The endoplasmic reticulum (ER) can be considered as the
gatekeeper for protein synthesis, assuring appropriate protein
folding and maturation of secreted and transmembrane proteins.
These functions are highly regulated and require checkpoint for
allowing that only correctly folded proteins can leave the ER.
Whenever the folding capacity of the ER is too low to meet the
cellular demand for newly synthesized proteins, unfolded or
misfolded proteins start to accumulate in the ER, which in turn,
triggers a set of responses known as the unfolded protein response
(UPR) [1–4]. The function of the UPR can be divided into two
major objectives, i.e. restoration of ER homeostasis and secondly
induction of apoptosis if the first objective fails. The UPR
accomplishes its function by increasing the expression of chaper-
one proteins to assist in protein folding, transient inhibition of
mRNA translation to decrease protein influx into the ER,
increasing ER associated degradation to remove misfolded
proteins and induction of apoptotic genes to eliminate cells that
are beyond repair.
The UPR consist of three different branches, each of which
containing a specific transmembrane ER sensor protein that, upon
activation, sets a series of responses in motion resulting in the
transcription of typical UPR target genes [3,4]. These so called
UPR sensor proteins are the inositol requiring kinase 1 (IRE1),
double-stranded RNA-activated protein kinase (PKR)-like ER
kinase (PERK) and activating transcription factor 6 (ATF6) [1–3],
all of which are associated with the ER chaperone glucose-
regulated protein BiP. If misfolded proteins accumulate, BiP
dissociates from the ER sensors, leading to their activation [1–3,5].
UPR sensor activation is characterized by cleavage of X-box-
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binding protein 1 (Xbp1) mRNA (IRE1), phosphorylation of the
translation initiation factor 2 a subunit (eIF2a) (PERK) and
processing of ATF6 in the Golgi apparatus [6–12] The UPR has
been implicated in a variety of diseases including cancer,
metabolic, neurodegenerative and inflammatory diseases [13]. In
addition it might be an integral part of the protective strategies
used by hibernating mammals for long term survival in a state of
cold torpor [14]. Signalling components of the UPR are emerging
as potential targets for intervention and treatment of human
disease [15].
Long chain polyunsaturated fatty acids are able to form
conjugates with amines, e.g. ethanolamine, serotonin or dopa-
mine. Since these conjugates can influence a variety of biological
systems, they are gaining increased attention as promising new
leads in the field of inflammatory and neurological disorders and
for other pharmacological applications [16]. Endogenous N-acyl
dopamines (NADD), e.g. N-arachidonoyl-, N-oleoyl-, N-palmitoyl-
and N-stearoyl-dopamine are present in brain tissue and are
known to modulate the endocannaboid system. It has also been
reported that NADD are able to activate transient receptor
potential (TRP) vanilloid subfamily member 1 (TRPV1) [17,18].
We recently described N-octanoyl-dopamine (NOD), a short
synthetic NADD, as a potent protective compound in acute kidney
injury [19]. In addition it prevents hypothermic preservation
injury [20,21], strongly inhibits platelet function [22] and impairs
NFkB activation [23]. Yet, it should be underscored that its
increased hydrophobicity, as compared to dopamine, may allow
NOD to cross intracellular membranes much easier where it may
severely change the redox milieu within subcellular compartments
[20]. Changes in redox milieu are either caused by donation of
reduction equivalents as a consequence of quinone formation or
by the iron chelating properties of the catechol structure [24]. In
keeping with the importance of redox homeostasis in the ER for
oxidative protein folding [25,26], the present study was conducted
to assess if synthetic N-acyl dopamine derivatives are able to
activate the UPR. In addition we sought to identify the structural
entities within NOD that might be important for UPR activation.
To this end we made use of synthetic NADD that were either
changed at the aromatic ring or in the aliphatic chain. We also
sought to address if activation of the UPR by NOD compromises
cell viability or if it represents a protective response, allowing cells




Reagents were obtained from the sources as indicated:
endothelial cell culture medium (Provitro, Berlin, Germany),
PBS, trypsin solution, ethanol (GIBCO, Invitrogen, NY, USA),
FBS Gold (PAA laboratories GmbH, Pasching, Austria), Actino-
mycin D, b-mercaptoethanol, tunicamycin, ethidium bromide,
EDTA solution, DMSO, Tween 20, phospahatase inhibitor
cocktail 2, Igepal 10%, collagenase, HEPES, Triton X-100,
DTT, sodium deoxycholate, Tris-base, ammonium persulphate,
SDS, TEMED, glycine, MTT, hexadimethrine bromide, acryla-
mid 40%, gelatine (Sigma-Aldrich, Taufkirchen, Germany),
bovine serum albumin (SERVA, Heidelberg, Germany), protease
inhibitor cocktail, first strand cDNA synthesis Kit (Roche
Diagnostic, Mannheim, Germany), Dual-Glo Luciferase Assay
System (Promega, Mannheim, Germany), Coomassie protein
assay reagent (Pierce, Rockford, IL, USA), Trizol (Invitrogen,
Carlsbad, CA, USA), chloroform, isopropanol, tetrahydrofuran,
(Merck, Darmstadt, Germany), anti-eIF2a, anti-phospho-eIF2a
(Cell Signalling, Boston, USA), anti-b-actin (Sigma, Taufkirchen,
Germany), Proteostat PDI assay kit (Enzo, Lo¨rrach, Germany),
Cignal Lenti ERSE/ATF6/positive control Reporter (luc) kit
(Qiagen, Du¨sseldorf, Germany). Chemiluminescence reagent was
purchased from PerkinElmer LAS Inc. (Boston, MA, USA).
Primers and all reagents were purchased for TaqMan PCR (ABI,
Darmstadt, Germany). Secondary antibodies conjugated with
horseradish peroxidase, anti-CHOP and anti-phospho-AMPK
were purchased from Santa Cruz Biotechnology (Heidelberg,
Germany).
Cell culture
Human umbilical vein endothelial cells (HUVECs) were
purchased from Promo Cell, Heidelberg, Germany and cultured
in basal endothelial medium supplemented with 10% fetal bovine
serum (FBS), essential growth factors and antibiotics. Cultures
were maintained at 37uC, 5% CO2 humidified atmosphere and
experiments were conducted on cells in passage 2–6 at approx-
imately 80–90% confluence.
Synthesis of N-acyl dopamines (NADD)
N-octanoyl dopamine (NOD), N-pivloyl dopamine (NPD) and
N-octanoyl tyramine (NOT) were synthesized from commercially
available precursors as previously described [20] and purified by
twofold recrystallization from dichloromethane as demonstrated
by thin layer chromatography (TLC). Octanoic or pivalic acid
were converted to their mixed anhydride derivate by reaction with
ethyl chloroformate in the presence of N-ethyl diisopropylamine.
The crude mixed anhydrides were incubated with dopamine
hydrochloride (Sigma-Aldrich, Taufkirchen, Germany) in N,N-
dimethylformamide and N-ethyl diisopropylamine to form NOD
or NPD. NOT was synthesized according to NOD using the
analog mixed anhydride coupled to tyramine as reaction
component. After aqueous preparation and evaporation of the
organic solvent NOD in an overall yield of approximately 60% is
obtained. The sample investigated by NMR (Bruker AC250)
yielded spectra in accordance with the expected structure.
Acetylation of NOD (A-NOD) was performed by suspending
two grams of NOD in 5 ml acetic anhydride under magnetic
stirring. When two drops of sulphuric acid were added, the
suspension turned clear and stirring was continued for one hour.
Diluted hydrochloric acid (5 mL) was added and 30 min later the
reaction mixture was poured into 200 ml ice water. The
precipitated product was collected by vacuum filtration and dried
under vacuum to yield A-NOD, pure as judged by thin layer
chromatography (TLC).
Gene expression profiling
Sample preparation and processing was performed according to
the Affymetrix GeneChip Expression Analysis Manual (http://
www.Affymetrix.com). Total RNA was isolated from HUVECs
using Trizol-Reagent (Life Technologies, Inc., Rockville, MD,
USA). DNase treatment was carried out, using RNase free DNase
I (Ambion, Woodward, Austin, TX, USA). RNA concentration
and quality were assessed by RNA 6000 nano assays on a
Bioanalyser 2100 system (Agilent, Waldbronn, Germany). 5 mg of
RNA was converted into cDNA using T7-(dT)24 primers and the
SuperScript Choice system for cDNA synthesis (Life Technologies,
Inc., Rockville, MD, USA). Biotin-labelled cDNA was prepared by
in vitro transcription using the BioArray high yield RNA transcript
labeling kit (Enzo Diagnostics, Farmingdale, NY, USA). The
resulting cDNA was purified, fragmented and hybridized to
U133A gene chips (Affymetrix, Santa Clara, CA, USA). After
hybridization the chips were stained with streptavidin–phycoery-
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thrin (MoBiTec, Goettingen, Germany) and analysed on a
GeneArray scanner (Hewlett Packard Corporation, Palo Alto,
CA, USA).
Microarray processing and statistical analysis
Gene expression profiling was performed using arrays of
HG_U133A 2.0-type from Affymetrix. A Custom CDF Version
13 with Entrez based gene definitions was used to annotate the
arrays. The Raw fluorescence intensity values were normalized
applying quantile normalization. Differential gene expression was
analysed OneWay-ANOVA using a commercial software package
SAS JMP7 Genomics, version 4, from SAS (SAS Institute, Cary,
NC). A false positive rate of a=0.05 with FDR correction was
taken as the level of significance. The raw and normalized data are
deposited in the Gene Expression Omnibus database (http://
www.ncbi.nlm.nih.gov/geo/; accession No. GSE- 56285).
RNA isolation, PCR and RNA stability
Total RNA was isolated as described above. 1 mg of total RNA
was reverse-transcribed into cDNA using the 1st Strand cDNA
Synthesis Kit. cDNA was diluted in 20 mL DEPC-treated water
and stored at 220uC until use. qPCR was performed on a ABI-
Prism 7700 sequence detection system using TaqMan universal
PCR master mix AmpErase UNG (part no. 4324018). The
following Taqman assays were used: BiP (part
No. Hs00607129_gH), CHOP (part No. Hs00358796_g1),
PDIA4 (part No. Hs00202612_m1), ERO1L (part
No. Hs00205880_m1) and GAPDH (part No. Hs02758991_g1).
Samples were run under the following conditions: initial denatur-
ation for 10 min at 95uC followed by 40 cycles of 15 s at 95uC and
1 min at 60uC. The levels of gene expression in each sample were
determined with the comparative cycle threshold method. PCR
efficiency was assessed from the slopes of the standard curves and
was found to be between 90% and 100%. Linearity of the assay
could be demonstrated by serial dilution of all standards and
cDNA. All samples were normalized for an equal expression of
GAPDH. For RT-PCR 1 mL of cDNA was amplified in a 20 mL
reaction mix containing 2,5 mmol?L–1 dNTPs, 25 pmol?L–1 of
each primer, 0,125 units Taq polymerase and 0,5 mmol?L–1
MgCl2. The following primers were used: : GAPDH forward: 59-
GTC TTC ACC ACC ATG GAG AA-39 and reserve: 59- ATC
CAC AGT CTT CTG GGT GG-39, Xbp1 forward: 59- CCT
TGT AGT TGA GAA CCA GG -39 and reverse 59-GGG GCT
TGG TAT ATA TGT GG-39. The cycling conditions used for
Table 1. Up-regulation of genes by NOD (NOD-treated vs. not treated cells).





























a: p-values for the comparison are given as log10 value. UPR target genes are depicted in bold.
doi:10.1371/journal.pone.0099298.t001
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Figure 1. Induction of the UPR by NOD. (a) HUVECs were transduced by lentiviral particles containing either an ERSE- luciferase reporter or a
luciferase construct under control of a CMV driven promoter as transduction efficiency control. The cells were stimulated for 8 hrs with 25 mM, 50 mM
and 100 mM of NOD as indicated. Luciferase activity was assessed as described in materials and methods and normalized for constitutively expressed
luciferase. The results are expressed as normalized ESRE luciferase activity relative to untreated (0 mM) cells. Values represent mean 6 SD from three
independent experiments. *P,0.05, **P,0.01 vs. untreated control. (b) HUVECs were treated with 100 mM NOD for the indicated time periods. Total
RNA was isolated and the expression of BiP and GAPDH was assessed by qPCR. The results are expressed as BiP mRNA levels, normalized for GAPDH
and relative to cells that were not treated. *P,0.05, **P,0.01 vs. untreated control. (c) HUVECs were treated with 100 mM NOD for the indicated time
periods. Hereafter protein extracts were made and phosphorylation of eIF2a was assessed by Western blotting. The blots were stripped and re-
probed with antibodies directed against total eIF2a and b-actin to test for equal loading. The results of a representative blot are depicted, a total of 4
independent experiments were performed. (d) HUVECs were treated for 4 and 24 hrs with 100 mM of NOD before total RNA was isolated. Cells that
were not treated (Med.) served as control. Spliced and unspliced xbp-1 mRNA were detected by PCR. The spliced and unspliced amplification
products differ by 26 bp. (e) Cells were transduced with lentiviral particle containing an ATF-6-driven luciferase reporter or a luciferase construct
under control of a CMV driven promoter as transduction efficiency control. The cells were stimulated for different time periods with NOD 100 mM.
Luciferase activity was assesses as described in materials and methods and normalized for constitutively expressed luciferase. The results are
expressed as normalized ATF6 luciferase activity relative to timepoint 0. Values represent mean6 SD from three independent experiments. **P,0.01,
* P,0.05 vs. untreated control, ns: no significant.
doi:10.1371/journal.pone.0099298.g001
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various primers were as follows: 4 min of denaturation at 94uC,
followed by 30 (Xbp1) or 25 (GAPDH) cycles of amplification,
each consisting of denaturation for 30 s at 94uC, annealing for
30 s at 58uC (Xbp1) and 55uC (GAPDH) and extension for 1 min
at 72uC. In all experiments GAPDH was used as housekeeping
gene, no differences were found for the conditions tested when b-
actin was used. After the last amplification a final extension for
10 min at 72uC was performed for each reaction. PCR products
were analysed on a 4% NuSieve agarose gel containing ethidium
bromide and run at 50 V for 6 hrs.
Lentiviral transduction and reporter assays
To evaluate activation of UPR pathways, cells were transfected
with commercially available reporter constructs as ready-to use
transducer lentiviral particles (Qiagen, Du¨sseldorf, Germany). One
day before transduction cells were seeded in 96-well plates (104/
well) and cultured overnight. Hereafter, the cells were transduced
at an MOI of 5 using 8% polybrene. Five hrs after transduction 3
volumes of fresh cell growth medium was added and the cells were
incubated overnight. Cell growth medium was replaced the next
day and 24 hrs hereafter the cells were treated with NADD
according to the specific experiment. Luciferase activity was
evaluated by a commercially available luciferase assay system
(Promega, Mannheim, Germnay) according to the manufacturer’s
protocol.
Protein extraction and Western blot Analysis
HUVEC lysed in 20 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 1 mM
dithiothreitol (DTT) buffer containing proteinase and phosphatase
inhibitors. In some experiments, nuclear proteins were isolated as
previously described [27]. Protein concentrations were measured
using Coomassie-Reagent (Pierce, Rockford, USA). Samples
(20 mg protein extract) were heated to 95uC for 5 minutes, loaded
and separated on 10% SDS-polyacryamide gels followed by semi-
dry blotting onto PVDF membranes (Roche, Mannheim,
Germany). The membranes were incubated with 5% w/v non-
fat dry milk or bovine serum albumin in TBS/Tween 0.5% to
block unspecific background staining and hereafter incubated
overnight at 4uC with the specific mono- or polyclonal eIf2a and
p-eIf2a (Cell Signaling, Boston, USA), anti- CHOP and anti-
pAMPK (Santa Cruz, Heidelebrg, Germany). Subsequently, the
membranes were thoroughly washed with TBS-Tween 0.1% and
incubated with the appropriate horseradish peroxidise conjugated
secondary antibody (Santa Cruz, Heidelberg, Germany), followed
by five times wash in TBS/Tween 0,1%. Proteins were visualized
using enhanced chemo luminescence technology, according to the
manufacturer’s instructions (Pierce, Rockford, IL). To confirm
equal protein loading, membranes were stripped and re-probed
with monoclonal anti-b-actin antibody (Sigma, Taufkirchen,
Germany).
PDI activity assay
PDI activity was assessed in a test tube using a commercially
available assay ProteoStat PDI assay kit (Enzo Life Sciences,
Lo¨rrach, Germany). The assay was performed as recommended
by the manufacturer.
FACS anaylsis
Cell apoptosis and cell cycle analysis were assessed by FACS.
For cell apoptosis HUVEC were stimulated with NOD (100 mM)
or Tunicamycin (1 mg/ml) for 24 hrs followed by Annexin V/PI
staining (Life Technologies, Darmstadt, Germany). For cell cycle
analysis HUVEC were stimulated with NOD (100 mM) for 24 hrs.
After stimulation the cells were harvested by trypsin, washed three
times with phosphate-buffered saline (PBS), and stained for 15 min
at room temperature with 5 ml of Annexin V–FITC and 10 ml of
PI (5 mg/ml) in 1 binding buffer (10 mM HEPES, pH 7.4, 140 mM
NaOH, 2.5 mM CaCl2). For cell cycle analysis the cells were
stained with DRAQ5 (Biostatus Lim., Shephsed, UK) at a final
concentration of 10 mM according to the supplier’s protocol. For
all experiments cells were analyzed on a FACS Calibur flow
cytometer (BD Biosciences, Heidelberg, Germany). At least 50,000
gated events were collected per sample and data were analyzed by
Flowjo software (Tree Star, Inc., Ashland, OR, USA).
Proliferation assay
HUVECs were seeded in multiple cell densities (26103–86103)
in a 96-well plate and cultured in 100 ml of complete medium for
24 hrs. Hereafter cells were treated with different concentrations
of NOD for 24 hrs and pulsed with 0.2 mCi of [6-3H] thymidine/
well (Perkin Elmer, Groningen, The Netherlands) during the last
16 h of culture. All conditions were tested on six replicates culture
wells. Incorporated 3Hthymidine was assessed by scintillation
Figure 2. Molecular structure of NADD used in the study.
doi:10.1371/journal.pone.0099298.g002
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counting in a liquid scintillation counter (LS 6500, Beckman
Coulter, Krefeld, Germany).
Intracellular ATP measurement
Cells were cultured from passage 2 till passage 6 in the presence
or absence of NOD (1 mM). At passage 6 the cells were seeded in
6-well plates and were cutured for additional 2days. Hereafter cells
were harvested by trypsin, counted and 500.000 cells pro
condition were lysed in 200 ml of lysis buffer (100 mM Tris,
4 mM EDTA, pH 7.7). Lysates were collected and ATP
concentrations were assessed directly hereafter using a commer-
cially available ATP-driven luciferase assay according to the
manufacturer’s instruction (Roche Diagnostics, Mannheim, Ger-
many). All experimental conditions were tested in triplicates in at
least 3 different experiments.
LDH assay
Tolerance to hypothermia associated cell damage was assessed
by lactate dehydrogenase (LDH) release. To this end, HUVEC
were cultured from passage 2 till passage 6 in the presence or
absence of NOD (1 mM). At passage 6 the cells were seeded in 24-
well plates and were cultured for additional 2 or 5 days in the
absence of NOD. Shortly before subjecting the cells to cold storage
the medium was changed to phenol red free and cells were stored
for 24 hrs at 4uC. Cell damage was assessed by LDH release in the
supernatant, according to manufacturer’s instructions (Roche
diagnostics, Mannheim, Germany). All experimental conditions
were tested in triplicate in at least 3 different experiments.
Statistical analysis
All data are expressed as the means 6 SD from at least three
independent experiments. Statistical significance was assessed by
one-way ANOVA (Dunnett’s and Tukey test) and P,0.05 was
considered to be significant.
Results
Induction of the UPR by NOD
To investigate if N-octanoyl dopamine (NOD) induces the
UPR, we screened by genome wide gene expression profiling in
HUVECs for genes that were up regulated by NOD. To this end,
three different primary cultures of HUVECs were treated with
100 mM NOD for 24 hrs or left untreated. The results of the top
30 genes that showed up-regulation are depicted in Table 1.
Thirteen out of these have been reported to be UPR target genes
[3,11,28]. Up-regulation of the 5 most influenced UPR target
genes was confirmed in independent experiments by qPCR (data
not shown). The raw and normalized data are deposited in the
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.
gov/geo/; accession No. GSE- 56285).
To further substantiate our affymetrix findings and to confirm
that NOD treatment induces the UPR we made use of a cis acting
ER-stress response element (ERSE) - containing luciferase reporter
construct. Luciferase expression increased upon NOD treatment
in lentiviral transduced HUVEC in a dose-dependent fashion
(Figure 1a). Since these cis acting elements are present in the
promoter of BiP, we assessed the influence of NOD on BiP mRNA
expression. In line with the ERSE reporter assay it was found that
BiP mRNA transiently increased upon NOD treatment, with
maximal expression occurring at 8 hrs of stimulation (Figure 1b).
NOD did not selectively activate one particular proximal UPR
sensor as PERK, IRE1 and ATF6 were all transiently activated.
Phosphorylation of eIF2a was in most experiments evident after
24 hrs of NOD treatment. In some experiments phosphorylation
was also noted at 8 hrs, but was persistently absent at later time
points (Figure 1c). Similarly, IRE1 and ATF6 were transiently
activated upon NOD treatment. Xbp1 splicing (Figure 1d) and
ATF6 induced luciferase expression (Figure 1e) were maximal at 4
and 8 hrs respectively, with decreasing tendency at later time
points.
Structural requirements of NOD for UPR induction
To assess the structural requirements for UPR induction by
NOD we used NOD as lead compound and subsequently changed
the functional groups at the aromatic ring or exchanged the
octanoyl - for the more bulky pivaloyl moiety. The changes at the
Figure 3. Induction of the UPR by NADD variants. (a) HUVECs
were transduced by lentiviral particles containing either an ERSE-
luciferase reporter or a luciferase construct under control of a CMV
driven promoter as transduction efficiency control. The cells were
stimulated for 8 hrs with 100 mM of different NADD as indicated.
Equimolar concentrations of dopamine were also included to assess if
dopamine induces the UPR. ERSE dependent luciferase activity was
assessed as described in materials and methods and normalized for
constitutively expressed luciferase. The results are expressed as
normalized ESRE luciferase activity relative to untreated (Med.) cells.
Values represent mean6 SD from three independent experiments, *P,
0.05, **P,0.01 vs. untreated control, ns: not significant. (b) HUVECs
were treated with 100 mM NADD for 8 hrs. Cells that were not treated
(Med.) served as control. Hereafter total RNA was isolated and the
expression of BiP and GAPDH were quantitated by qPCR. The results are
expressed as BiP mRNA levels, normalized for GAPDH mRNA expression
and relative to cells that were not treated (Med), *P,0.05, **P,0.01 vs.
untreated control, ns: not significant. (c) HUVECs were stimulated for
8 hrs with 100 mM of different NADD, or left untreated (Med). Hereafter
protein extracts were made and phosphorylation of eIF2a was assessed
by Western blotting. The blots were stripped and re-probed with
antibodies directed against total eIF2a and b-actin to test for equal
loading. The results of a representative blot are depicted, a total of 4
independent experiments were performed. (d) HUVECs were stimulated
for 8 hrs with different NADD (100 mM) before total RNA was isolated.
Cells that were not treated (Med.) served as control. Spliced and
unspliced xbp-1 mRNA were detected by PCR. The spliced and
unspliced amplification products differ by 26 bp. (e) Cells were
transduced with lentiviral particle containing an ATF-6-driven luciferase
reporter or a constitutively expressed luciferase construct. The cells
were stimulated for 8 hrs with different NADD (100 mM). Luciferase
activity was assessed as described in materials and methods and
normalized for constitutively expressed luciferase activity. The results
are expressed as normalized ATF6 luciferase activity relative to
untreated (Med.) cells. Values represent mean 6 SD from three
independent experiments, *P,0.05, **P,0.01, vs. untreated control,
ns: no significant.
doi:10.1371/journal.pone.0099298.g003
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Figure 4. NOD inhibits PDI activity. (a) PDI activity was assessed by monitoring PDI-catalyzed reduction of insulin in the presence of
Dithiothreitol (DTT) and different concentrations of NOD. Bacitracin in concentrations of 1 and 10 mM was used to validate the assay. (b). Different
NADD were tested for inhibition of PDI activity in a similar manner as described in (a). The results from three independent experiments are expressed
as mean % PDI activity 6 SD, using PDI activity in the absence of inhibitors (2) as 100%, *P,0.05, **P,0.01 vs. untreated control, ns: no significant.
doi:10.1371/journal.pone.0099298.g004
Figure 5. NOD does not impair cell viability. (a) HUVECs were treated for 24 hrs with NOD (100 mM) or tunicamycin (TM, 1 mg/ml). In addition
cells were treated for 3 hrs with 100 mM of NOD prior to tunicamycin treatment. Cells that were not treated (Med.) served as control. Both floating
and adherent cells were harvested, stained for Annexin V and 7-AAD and analysed by flow cytometry. (b) HUVECs were treated with 100 mM NOD or
TM (1 mg/ml) for the indicated time periods. Total RNA was isolated and expression of CHOP mRNA was assessed by qPCR and normalized for GAPDH
(left panel). Cells were pre-treated either with NOD or with tunicamycin and then chased for 0, 2, 4 and 8 hrs with AcD 50 ng/ml. Total RNA was
isolated and the expression of CHOP (middle panel) and BiP (right panel) mRNA were assessed by qPCR and normalized for GAPDH. The results of
three different experiments are expressed as mean mRNA levels 6 SD, ** P,0.01 vs. untreated cells.
doi:10.1371/journal.pone.0099298.g005
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aromatic ring included, omission of one hydroxyl group (N-
octanoyl tyramine (NOT) and acetylation of the hydroxyl-groups
(A-NOD). While NOT has a significant lower redox activity
compared to NOD, in A-NOD oxidation of the masked catechol
structure can only occur intracellular. Moreover acetylation of the
hydroxy groups makes the molecule more polar which may
facilitate cellular uptake. The presence of the bulky pivaloyl moiety
in N-pivaloyl dopamine (NPD) makes the ester more resistant to
hydrolysis [29] (Figure 2). Using the ERSE- containing luciferase
reporter construct, it was shown that only the redox active
compounds NOD, A-NOD and to a lesser extent NPD were able
to increase luciferase expression in lentiviral transduced HUVEC,
while the redox inactive NOT showed no effect (Figure 3a). In line
with these findings, increased BiP mRNA expression and ER-
sensor activation (Figure 3b–e) only occurred by the redox active
NADD variants. It should be mentioned however that with
exception of the ATF6 reporter assay, in all other assays NPD was
consistently weaker compared to NOD and A-NOD. In contrast
to the NADD variants, equimolar concentrations of dopamine
were not able to activate the UPR (Figure 3a and b).
Since oxidative folding in the ER is catalyzed by protein
disulfide isomerase (PDI) we assessed in a test tube assay if PDI
activity was impaired by NOD. The known PDI inhibitor
bacitracin was included to validate the assay and showed
inhibition of 65 and 15% at a concentration of 1 and 10 mM
respectively (Figure 4a). Although NOD was clearly less effective
compared to bacitracin, NOD inhibited PDI in a dose dependent
manner with an almost 50% inhibition at 10 mM. A-NOD and
NPD did not inhibit PDI activity (Figure 4b).
NOD does not impair cell viability
In keeping with the fact that induction of the UPR may result in
apoptosis, we sought to address if NOD treatment affects cell
viability. Cell viability was assessed by means of FACS analysis
using Annexin V/7-ADD (Figure 5a). While tunicamycin, a
known UPR inducer, clearly increased the percentage of 7-AAD
single and Annexin V/7-ADD double positive cells, this was not
observed for NOD (Figure 5a). Interestingly, when HUVEC were
treated with NOD 3 hrs prior to the addition of tunicamycin, the
number of both 7-AAD single and Annexin V/7-AAD double
Figure 6. NOD inhibits cell proliferation. (a) HUVECs were seeded in different cell densities in 96 well plates and the next day treated for 48 hrs
with different concentrations of NOD. During the last 16 hrs the cells were pulsed with 0.2 mCi 3[H] thymidine and subsequently harvested. The
results of a representative experiment are depicted and expressed as mean 3H-thymidine incorporation in counts per minute (cpm) 6 SD of 6
replicate wells for each condition. A total of 6 experiments were performed with essentially similar results. Significance was defined as *P,0.05 and
**P,0.01 compared to untreated cells, ns: not significant. (b) In separate experiments HUVECs were stimulated with 100 mM of NOD or left untreated.
One part of the cells was used for cell cycle analysis, for the other part total RNA was isolated and the expression of AUROKA, CCNB1, CCNA2 and
CDK1 was assessed by qPCR (c). A total of three experiments were performed. The results in graph (b) are expressed as mean percentage of cells in
G0/1-, S- and G2/M- phase. *P,0.05, NOD vs. untreated. The results in graph (c) are expressed as normalized mRNA levels relative to the untreated
medium control cells. ** P,0.01 vs. untreated control.
doi:10.1371/journal.pone.0099298.g006
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positive cells decreased (Figure 5a). Transient induction of CHOP
mRNA was observed for both NOD and tunicamycin, albeit that
CHOP mRNA expression was significantly higher for the latter
condition (Figure 5b, left panel). No significant difference in
CHOP –mRNA stability was observed between NOD and
tunicamycin treated cells (Figure 5c, middle panel). However,
BiP mRNA was more stable in NOD treated cells than
tunicamycin-treated cells (Figure 5c, right panel).
Growth arrest, hypometabolism and thermotolerance
In the course of performing this study we consistently observed
that the time to confluence was much longer when HUVEC were
seeded in culture plates and treated with NOD. Consequently we
assessed if NOD affects cell proliferation. As demonstrated in 3[H]
thymidine incorporation assays, NOD dose dependently inhibited
cell proliferation (Figure 6a). NOD treatment changed cell cycle
phase distribution, with a relative increase of cells in the S-G2/M
phase (Figure 6b), suggesting that cell cycle progression was
attenuated at the S-G2/M phase. Importantly, affymetrix analysis
also showed a significant decreased mRNA expression for genes
involved in S-G2/M progression (table 2), which was confirmed by
qPCR (Figure 6c).
With exception of CHOP, all other UPR target genes tested in
this study were up-regulated in a dose dependent manner when
HUVEC were treated with low concentrations of NOD (0.1 and
1 mM) form the 2nd passage on until the 6th passage (P2 to P6)
(Figure 7a and b). In cells that were treated over this long period of
time with NOD, intracellular ATP concentrations were signifi-
cantly lower as compared to cells from a similar passage without
treatment (Figure 7c). The lower intracellular ATP concentration
was paralleled by an increased phosphorylation of AMPK
(Figure 7d), and was still noted when NOD was removed from
the culture 2 or 5 days prior to analysis. In addition to this
apparent hypo-metabolic state, cells were also more resistant to
cold inflicted injury as determined by LDH release (Figure 7e)
Discussion
In the present study we demonstrate that synthetic NADD
transiently activate the UPR. This property seems to be dependent
on the redox activity of these compounds. NOD did not affect cell
viability, but strongly impaired cell proliferation of HUVEC, most
likely by attenuation of cells in the S-G2/M phase. In concordance
to this, mRNA expression for a number of genes involved in S-
G2/M progression was significantly down-regulated by NOD.
Interestingly, long-term NOD treatment resulted in hypometab-
olism and thermotolerance, as suggested by a decreased intracel-
lular ATP concentration, activation of AMPK and increased
resistance to cold inflicted cell injury.
Sensing, responding, and adapting to environmental insults are
essential for all living organisms and are originating from
evolutionarily conserved unique signal transduction pathways.
Being one such a pathway, the role of the UPR is to alleviate ER
stress and, paradoxically, to activate apoptosis, depending on the
nature and severity of the stressor [30]. NADD are able to activate
the UPR mainly due to their redox active catechol structure, albeit
that at high NOD concentrations (10 mM) PDI activity was also
inhibited in a test tube assay. The latter seems to be a highly
unlikely explanation for UPR induction in HUVEC, since low
NOD concentrations (25 mM) already induced the UPR. It is
therefore more conceivable that oxidation of the catechol
containing NADD leads to donation of reduction equivalents,
thereby changing an oxidizing ER environment to a more
reducing one. This assumption is supported by the finding that
for NOT, which contains a low redox active tyramine moiety,
UPR induction was not observed. It should also be mentioned that
the hydrophobic fatty acid of NADD may facilitate UPR induction
by providing an easier access to the ER, in line with the
observation that despite its catechol structure dopamine was not
able to induce the UPR. We are aware that no definite proof that
NOD indeed has access to the ER is provided. However previous
published studies in which dopamine uptake was compared to that
of NOD [20] revealed that both dopamine and NOD were found
in the membrane fraction, which predominantly contains the ER
Table 2. Genes implicated in cell cycle, down-regulated by NOD.
















a: p-values for the comparison are given as log10 value.
doi:10.1371/journal.pone.0099298.t002
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compartment, as well as in the mitochondrial- and cytosolic
fraction. Hence, NOD may also impair the redox milieu in other
cellular compartments than the ER. It should be emphasized that
the ER enriched fraction also contained small amount of
mitochondrial proteins, and hence formal proof that NOD has
access to the ER compartment is still lacking.
The lower efficacy of NPD for UPR induction might reflect a
more limited access of NPD to the ER as a consequence of the
Figure 7. Long-term NOD treatment results in hypometabolism and thermotolerance. Three different primary HUVEC isolations were
cultured from P2 until P6 in the absence or presence of the indicated NOD concentrations. (a) BiP mRNA expression for cells cultured in the presence
of 0.1 and 1 mM NOD was assessed by qPCR. (b) CHOP, BiP, PDI4, and ERO1L mRNA expression for cells cultured in the presence of 0.1 mM NOD was
assessed by qPCR. The results in a and b are expressed as normalized mean mRNA levels relative to untreated controls (0, Med) 6 SD of 3 replicates
for each condition and for all 3 HUVEC isolations. ** P,0.01, *P,0.05 vs. untreated cells. (c) Intracellular ATP concentration was assessed in HUVEC at
P6 upon long-term culture in the absence (medium) or presence of NOD (1 mM). The results are expressed as mean ATP concentration (pmol/5*105
cells) 6 SD of 3 replicates for each condition and for all 3 HUVEC isolations. **P,0.01 vs. untreated cells (d,e). In separate experiments NOD (1 mM)
containing medium was exchanged for normal cell culture medium at P6 and the cells were cultured for 2 (2d) or 5 (5d) days in the absence of NOD.
Cells that were continuously cultured in normal cell culture medium (Med.) were used as control. In (d) protein extracts were made and assessed for
phosphorylation of AMPK (p-AMPK) by Western blotting. The blots were stripped and re-probed with antibodies directed against b-actin to test for
equal loading. The results of a representative blot are depicted, a total of 3 independent experiments were performed. In (e) the cells were subjected
to cold storage (4uC) for 24 hrs. Hereafter LDH release was assessed in the supernatants. Each condition was tested in triplicate in 2 independent
experiments. The results are expressed as mean LDH release (OD490) 6 SD, **P,0.01 vs. (Med.) control.
doi:10.1371/journal.pone.0099298.g007
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bulky pivanoyl fatty acid. Recently, Achard et al demonstrated
that the long-chain saturated palmitate (C16:0) fatty acid activates
the UPR [31], questioning as to whether UPR induction as
observed in our study could be mediated via intracellular
hydrolysis of NADD. This scenario is however unlikely because
hydrolysis of NOT would result in the release of octanoic acid
(C8:0), yet UPR induction was not observed when equimolar
concentrations of NOT were applied to HUVEC. The concen-
trations of palmitate used by Achard et al were significantly higher
compared to concentration of NOD at which UPR induction was
already noted (750 vs. 25 mM).
The decision mechanisms for switching the UPR from adaptive
response to apoptosis have so far been poorly understood. Cojocari
et al [32] recently suggested that the PERK signaling arm is
uniquely important for promoting adaptation and survival during
hypoxia-induced ER stress. Yet, other reports suggest that UPR
mediated cell adaptation is not due to selective UPR sensor
activation, but most likely reflects changes in protein composition
or mRNA stability of adapted cells [33]. Compared to tunicamy-
cin, NOD mediated induction of both CHOP and BiP mRNA was
modest, and may explain why tunicamicin, but not NOD treated
HUVEC went into apoptosis. Interestingly, in long-term NOD
(1 mM) treated HUVEC CHOP mRNA was down-regulated while
that of BiP was persistently up-regulated. This is in line with the
observation by Rutkowski et al [33] that over a long time course of
low ER stress CHOP up-regulation diminishes, despite persistent
up-regulation of the UPR-responsive ER chaperones BiP. It
remains to be assessed why prior NOD treatment of HUVEC,
abrogates tunicamycin mediated apoptosis, but it may well be a
consequence of altered UPR signaling [33–36].
Similar as reported by Rutkowski et al for tunicamycin [33], we
also observed that cell growth was retarded when cells were
continuously cultured in the presence of low NOD concentrations,
as suggested by an increased time to confluence. It has been
reported that phenolic compounds significantly affect cell prolif-
eration by arresting cells in the G2/M phase [37–40]. Therefore it
is at present unclear if growth inhibition by NOD is causally
related to UPR induction or if this is independent of the UPR.
AMP-activated protein kinase (AMPK) is a cellular energy
sensor that responds to low endogenous energy by stimulating fatty
acid oxidation. It acts as a low-fuel warning system that is activated
by depletion of ATP or, alternatively, by increased levels of AMP,
to induce an energy-saving state and to prevent lactate accumu-
lation and cell injury [41]. Since long term NOD treatment
resulted in decreased intracellular ATP concentrations it is
conceivable that this might have triggered the activation of
AMPK as observed in our study. More importantly, we also
observed that long term NOD treated HUVEC were more
resistant to cold inflicted injury. This effect was still apparent when
NOD was removed from the culture medium and cells were grown
for additional 2 or 5 days. These findings have important
implications as pre-conditioning strategies to improve organ
functioning after cold storage are primarily focused on influencing
cellular metabolism or energy status and reduction of inflamma-
tion [42]. Mamady H et al, have suggested that the UPR might be
integral to long term survival in a state of cold torpor by
coordinating gene expression responses that support the hibernat-
ing phenotype [14]. However, it would be prudent to be cautious
in concluding that the apparent hypometabolism and thermo-
tolarance mediated by NOD are linked to UPR induction.
We have previously demonstrated that NOD has therapeutic
efficacy in ischemia induced acute kidney injury [19]. Induction of
the UPR has been suggested to be protective in a variety of
ischemia/reperfusion models [43–45]. It therefore remains to be
assessed if therapeutic concentrations of NOD are able to activate
UPR in vivo and to what extent this contributes to the reno-
protective effect of NOD in ischemia induced AKI.
NADD were first described as potent inhibitors of 5-lipoxygen-
ase [46,47] and through the discovery that NADD are highly
expressed in brain tissue, subsequent function have been revealed.
Now these conjugates have come to prominence because of their
potential roles in the nervous system, vasculature and the immune
system and are being explored as potential lead compounds in
drug development. The present finding that NADD have the
propensity to induce hypometabolism and thremotolerance,
irrespective as to whether this is mediated by UPR induction,
opens new perspectives in this regard.
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